Opko Health, Inc.

284 articles with Opko Health, Inc.

• Opko Health, Inc. Invests in Biotechnology Company Sorrento Therapeutics, Inc. Developing Human Antibody Library

  6/11/2009

• Opko Health, Inc. Announces Update on Phase III Clinical Trial of Bevasiranib; Company Decided to Terminate Clinical Study

  3/6/2009

• Opko Health, Inc. To Present Data on Next Generation Anti-Angiogenic VEGF165b-Sparing siRNA at Association for Research in Vision & Ophthalmology (ARVO 2009) Meeting

  2/10/2009

• Opko Health, Inc. Receives FDA 510(k) Clearance for Spectral OCT SLO Combination Imaging System

  1/23/2009

• Opko Health, Inc. Initiates Clinical Trial of the Aquashunt(TM) to Treat Glaucoma

  1/22/2009

• Opko Health, Inc. Announces Completion of Enrollment for Its Phase III Clinical Trial of Bevasiranib for Treatment of AMD

  12/4/2008

• Opko Health, Inc. Acquires Worldwide Ophthalmic Rights to Teva Pharmaceutical Industries Limited's Budesonide for Inflammatory and Allergic Ocular Conditions

  10/3/2008

• Opko Health, Inc. Set to Join Russell 3000 Index

  6/17/2008

• Opko Health, Inc. Acquires Rights to Novel Phase II Agent to Treat Viral Conjunctivitis

  6/12/2008

• Newly Published Study Shows Opko Health, Inc.'s siRNA Bevasiranib Is Taken Up by Target Tissues in the Eye

  6/3/2008

• Opko Health, Inc. Acquires Company Developing Novel Glaucoma Therapy

  5/7/2008

• Opko Health, Inc. Announces Issuance of U.S. Patent

  3/18/2008

• Opko Health, Inc. and Pathogenics Inc. Announce Data Publication Demonstrating the Potential Utility of NCT in a Severe Eye Infection

  2/25/2008

• Opko Health, Inc. Appoints Industry Veteran Dr. Naveed Shams as Chief Medical Officer

  1/14/2008

• Opko Health, Inc.'s Bevasiranib Named One of Most Promising Drugs Recently Entering Phase III Trials

  12/6/2007

• The Frost Group Invests $20 Million in Opko Health, Inc.

  12/5/2007

• Opko Health, Inc. Completes Acquisition of Ophthalmic Technologies, Inc.

  11/29/2007

• Opko Health, Inc. Acquires Rights to Innovative Ocular Product to Prevent Serious Eye Infections

  10/30/2007

• Opko Health, Inc. Acquires Rights to Clinical Stage Compound for Dry Eye

  10/11/2007

• Opko Health, Inc. to Present at UBS Warburg 2007 Global Life Sciences Conference

  9/18/2007